Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy

ClinicalTrials.gov ID: NCT01443403

Public ClinicalTrials.gov record NCT01443403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine efficacy and safety of naldemedine for the treatment of opioid-induced constipation in adults with non-malignant chronic pain receiving opioid therapy for ≥ 3 months.

Study identification

NCT ID
NCT01443403
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shionogi
Industry
Enrollment
244 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 17, 2011 (Actual)
Primary completion
Aug 22, 2012 (Actual)
Completion
Aug 22, 2012 (Actual)
Last update posted
Jun 26, 2017

2011 – 2012

United States locations

U.S. sites
49
U.S. states
24
U.S. cities
49
Facility City State ZIP Site status
Shionogi Research Site Phoenix Arizona — —
Shionogi Research Site Sun Lakes Arizona — —
Shionogi Research Site Little Rock Arkansas — —
Shionogi Research Site Anaheim California — —
Shionogi Research Site Fresno California — —
Shionogi Research Site Lincoln California — —
Shionogi Research Site Lomita California — —
Shionogi Research Site Denver Colorado — —
Shionogi Research Site Brandon Florida — —
Shionogi Research Site Kissimmee Florida — —
Shionogi Research Site New Port Richey Florida — —
Shionogi Research Site North Miami Florida — —
Shionogi Research Site Ocala Florida — —
Shionogi Research Site Orlando Florida — —
Shionogi Research Site Ormond Beach Florida — —
Shionogi Research Site Port Orange Florida — —
Shionogi Research Site Sarasota Florida — —
Shionogi Research Site South Miami Florida — —
Shionogi Research Site West Palm Beach Florida — —
Shionogi Research Site Atlanta Georgia — —
Shionogi Research Site Decatur Georgia — —
Shionogi Research Site Marietta Georgia — —
Shionogi Research Site Evansville Indiana — —
Shionogi Research Site Lexington Kentucky — —
Shionogi Research Site Shreveport Louisiana — —
Shionogi Research Site Owings Mills Maryland — —
Shionogi Research Site Watertown Massachusetts — —
Shionogi Research Site Worcester Massachusetts — —
Shionogi Research Site Traverse City Michigan — —
Shionogi Research Site Edina Minnesota — —
Shionogi Research Site Las Vegas Nevada — —
Shionogi Research Site Newington New Hampshire — —
Shionogi Research Site Berlin New Jersey — —
Shionogi Research Site Willingboro New Jersey — —
Shionogi Research Site Hartsdale New York — —
Shionogi Research Site North Syracuse New York — —
Shionogi Research Site Williamsville New York — —
Shionogi Research Site Wilmington North Carolina — —
Shionogi Research Site Winston-Salem North Carolina — —
Shionogi Research Site Canton Ohio — —
Shionogi Research Site Columbus Ohio — —
Shionogi Research Site Perrysburg Ohio — —
Shionogi Research Site Eugene Oregon — —
Shionogi Research Site Philadelphia Pennsylvania — —
Shionogi Research Site Greer South Carolina — —
Shionogi Research Site Austin Texas — —
Shionogi Research Site Dallas Texas — —
Shionogi Research Site Orem Utah — —
Shionogi Research Site Salt Lake City Utah — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01443403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01443403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →